Treat your central sleep apnea patients–without masks or medications–with the remedē® System
Clinically proven to reduce the effects of CSA
The remedē® System is a proven, implantable sleep therapy specifically designed for treating Central Sleep Apnea (CSA) in a way that closely resembles the body’s natural physiology. It has demonstrated consistent and sustained long-term safety and effectiveness benefits that have shown to reduce the severity of CSA, improve sleep, breathing and quality of life.1
78% of patients reported quality of life improvement using the Patient Global Assessment1
96% reduction in the median Central Apnea Index at 1 year2
95% of patient reported they would “elect to have the medical procedure again”1
Improvements in sleep
and quality sustained
out to 5 years2
remedē Patient Pathway
The remedē patient pathway is an educational service providing resources for screening, patient selection, device implant and therapy optimization and follow up.
- Costanzo MR, Ponikowski P, Javaheri S, et al. Sustained Twelve Month Benefit of Phrenic Nerve Stimulation for Central Sleep Apnea. Am J Cardiol. 2018. pii: S0002-9149(18)30258-3. doi: 10.1016/j.amjcard.2018.02.022.
- Costanzo MR, Javaheri S, Ponikowski P, et al. Transvenous Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea: Five-Year Safety and Efficacy Outcomes. Nat Sci Sleep. 2021;13:515-526